What do the new ESC Guidelines for the treatment of heart failure bring to internists?

Česká verzia

Authors: Jindřich Špinar; Lenka Špinarová; Jiří Vítovec
Authors place of work: I. interní kardioangiologická klinika FN USA a LF MU, Brno
Published in the journal: Vnitř Lék 2022; 68(2): 104-110
Category: Review Articles

Summary

Chronic heart failure is in european countries in 0,4–2,0% population with an increase with age. The improved care of acute cases enables to decrease the number of patients with chronic heart failure.The disease has a bad prognosis, the diagnosis therapy are demanding. European guidelines for diagnosis and treatment heart failure stress, that patients should have all 4 drugs with class 1 reccomendation (ACE‑ I/ARNI, betablockers, MRA and SGLT2) in reccomended doses. These drugs will be given step by step with dose titration.

Keywords:

diagnosis – treatment – chronic heart failure

Zdroje

1. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European heart journal. 2021;00:1-128. doi: 101093/eurheartj/ehab 368.